These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 26807724)
1. Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. Lanza NL; McClellan AL; Batawi H; Felix ER; Sarantopoulos KD; Levitt RC; Galor A Ocul Surf; 2016 Apr; 14(2):216-23. PubMed ID: 26807724 [TBL] [Abstract][Full Text] [Related]
2. The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye. Lanza NL; Valenzuela F; Perez VL; Galor A Ocul Surf; 2016 Apr; 14(2):189-95. PubMed ID: 26850527 [TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay. Messmer EM; von Lindenfels V; Garbe A; Kampik A Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes. Chan TC; Ye C; Chan KP; Chu KO; Jhanji V Br J Ophthalmol; 2016 Sep; 100(9):1188-91. PubMed ID: 26682569 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. Sambursky R; Davitt WF; Latkany R; Tauber S; Starr C; Friedberg M; Dirks MS; McDonald M JAMA Ophthalmol; 2013 Jan; 131(1):24-8. PubMed ID: 23307206 [TBL] [Abstract][Full Text] [Related]
6. [A preliminary study on the tear matrix metalloproteinase 9 point-of-care assay using a domestic kit]. Wan XC; Zhang H; Shen Y; Zhou SY; Yang P; Zhou XJ; Gu H; Le QH; Xu JJ; Zhou XT; Hong JX Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):272-278. PubMed ID: 37012590 [No Abstract] [Full Text] [Related]
7. Changes in the Matrix Metalloproteinase 9 Point-of-Care Test Positivity According to MMP-9 Concentration and Loading Volume. Huh J; Choi SY; Eom Y; Kim HM; Song JS Cornea; 2020 Feb; 39(2):234-236. PubMed ID: 31369458 [TBL] [Abstract][Full Text] [Related]
8. Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay. Jun JH; Lee YH; Son MJ; Kim H PLoS One; 2020; 15(7):e0235408. PubMed ID: 32649686 [TBL] [Abstract][Full Text] [Related]
9. Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease. Sambursky R; Davitt WF; Friedberg M; Tauber S Cornea; 2014 Aug; 33(8):812-8. PubMed ID: 24977985 [TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Ocular Itch, Ocular Pain, and Dry Eye Symptoms (An American Ophthalmological Society Thesis). Galor A; Small L; Feuer W; Levitt RC; Sarantopoulos KD; Yosipovitch G Trans Am Ophthalmol Soc; 2017 Aug; 115():T5. PubMed ID: 29391860 [TBL] [Abstract][Full Text] [Related]
11. Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. Sambursky R Clin Ophthalmol; 2016; 10():2337-2343. PubMed ID: 27920494 [TBL] [Abstract][Full Text] [Related]
12. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients. Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Somatosensory Function in Patients With Idiopathic Dry Eye Symptoms. Galor A; Levitt RC; McManus KT; Kalangara JP; Seiden BE; Park JJ; Covington DB; Sarantopoulos CD; Felix ER JAMA Ophthalmol; 2016 Nov; 134(11):1290-1298. PubMed ID: 27685701 [TBL] [Abstract][Full Text] [Related]
14. Association of tear matrix metalloproteinase 9 immunoassay with signs and symptoms of dry eye disease: A cross-sectional study using qualitative, semiquantitative, and quantitative strategies. Lee YH; Bang SP; Shim KY; Son MJ; Kim H; Jun JH PLoS One; 2021; 16(10):e0258203. PubMed ID: 34662364 [TBL] [Abstract][Full Text] [Related]
15. The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Kaufman HE Cornea; 2013 Feb; 32(2):211-6. PubMed ID: 22673852 [TBL] [Abstract][Full Text] [Related]
16. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Pouyeh B; Viteri E; Feuer W; Lee DJ; Florez H; Fabian JA; Perez VL; Galor A Am J Ophthalmol; 2012 Jun; 153(6):1061-66.e3. PubMed ID: 22330309 [TBL] [Abstract][Full Text] [Related]
17. Association of Ramadan daytime fasting with ocular surface inflammation and dry eye. Armstrong BK; Coc IR; Agarwal P; Smith S; Navon S Int Ophthalmol; 2019 Dec; 39(12):2857-2863. PubMed ID: 31152289 [TBL] [Abstract][Full Text] [Related]
18. Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain. Crane AM; Feuer W; Felix ER; Levitt RC; McClellan AL; Sarantopoulos KD; Galor A Br J Ophthalmol; 2017 Sep; 101(9):1238-1243. PubMed ID: 28100479 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears. Kim DW; Seo JH; Lim SH Eye (Lond); 2021 Mar; 35(3):892-900. PubMed ID: 32472047 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of discordance between symptoms and signs of dry eye. Ong ES; Felix ER; Levitt RC; Feuer WJ; Sarantopoulos CD; Galor A Br J Ophthalmol; 2018 May; 102(5):674-679. PubMed ID: 28821553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]